论文部分内容阅读
目的:观察改良保肾方Ⅱ号对糖尿病肾病患者的临床疗效。方法:将79例2型糖尿病肾病患者分为治疗组和对照组,两组病人均予基础治疗即:控制饮食、血糖、血压、血脂。在此基础上,治疗组加用改良保肾方Ⅱ号中药汤剂,两组疗程均为3个月。观察两组治疗前后中医证候评分、尿蛋白定量、肾小球滤过率、糖化血红蛋白及血脂等指标变化。结果:治疗组总有效率87.50%,对照组总有效率61.54%,两组比较差异有统计学意义(P<0.05)。两组治疗后中医证候评分、24h尿蛋白定量较治疗前均有下降(P<0.05),但治疗组明显优于对照组(P<0.05)。两组治疗前后肾小球滤过率无明显差异(P>0.05)。两组治疗后糖化血红蛋白、总胆固醇、甘油三酯均较治疗前有显著改善(P<0.05),但组间比较无明显差异(P>0.05)。结论:改良保肾方Ⅱ号能够明显降低糖尿病肾病患者的尿蛋白,改善临床症状,治疗糖尿病肾病具有显著疗效。
Objective: To observe the clinical effect of Modified Bao Shen Fang Ⅱ on patients with diabetic nephropathy. Methods: 79 patients with type 2 diabetic nephropathy were divided into treatment group and control group. Both groups were given basic treatment, namely diet, blood glucose, blood pressure and blood lipid. On this basis, the treatment group plus improved traditional Chinese medicine Decoction No. 2 decoction, both treatment courses were 3 months. Before and after treatment, TCM syndrome score, urinary protein quantitation, glomerular filtration rate, glycosylated hemoglobin and blood lipid were observed. Results: The total effective rate was 87.50% in the treatment group and 61.54% in the control group. The difference between the two groups was statistically significant (P <0.05). After treatment, the scores of TCM syndromes and 24-h urinary protein in both groups were lower than those before treatment (P <0.05), but the treatment group was significantly better than the control group (P <0.05). Glomerular filtration rate before and after treatment showed no significant difference (P> 0.05). After treatment, HbA1c, total cholesterol and triglyceride were significantly improved in both groups (P <0.05), but there was no significant difference between the two groups (P> 0.05). Conclusion: Modified Bao Shen Fang Ⅱ can significantly reduce diabetic nephropathy in patients with urinary protein, improve clinical symptoms, the treatment of diabetic nephropathy has a significant effect.